NEW YORK – Roche announced Tuesday its Accu-Check SugarView app, a blood glucose monitor designed to help non-insulin-dependent patients with type 2 diabetes manage their condition between doctors' visits, received the CE mark.
The app, now officially classified as in vitro diagnostics software, determines blood glucose ranges via photos taken with the phone camera, without needing a blood glucose meter. It uses the Accu-Check Active test strip and two photos taken off the strip with a smartphone camera to assign the blood glucose result on the strip to a category ranging from low to very high. The app then combines the blood glucose range with information on actions to take, like exercise or eating.
Roche said the app will be available in the Google Play store for certain smartphone models.
"The broad launch of this state-of-the art digital solution can offer a huge benefit to people in-between doctors' visits and to those not having access to appropriate diabetes care and blood glucose monitoring," Marcel Gmuender, the global head of Roche Diabetes Care, said in a statement. "The app enables availability of relevant therapy information and support in everyday life."